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ORIGINAL ARTICLE
Early postoperative complications in patients with Crohn’s disease
given and not given preoperative total parenteral nutrition
STEFAN JACOBSON
The Department of Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden
Abstract
Objective. The effect of preoperative total parenteral nutrition (TPN) on the rate of early (within 30 days) postoperative
complications in patients with moderate to severe Crohn’s disease (CD) was examined. Material and methods. As e r i e s
of 15 consecutive patients with CD (mean CD activity index score, 270) given preoperative TPN for 18–90 days (mean,
46 days) and undergoing bowel resection and primary anastomosis was compared with matching controls (105 patients)
consecutively selected from all CD patients operated in Stockholm County during a preceding 20-year period without
preoperative TPN. Results. D u r i n gt h ep r e o p e r a t i v eT P N ,a l lt h ep a t i e n t ss tudied displayed clinical remission of CD as
reﬂected in improvement in their general well-being, relief of abdominal pain, and abatement of fever and diarrhea.
There was no signiﬁcant early postoperative complication in the TPN-treated group, whereas there were 29 patients with
early postoperative complications in the control group, which means a signiﬁcantly higher rate of postoperative complica-
tions when preoperative TPN was not provided. During the preoperative TPN, some crucial variables increased such as
the body weight, the serum concentrations of albumin and triiodothyronine reﬂecting improved nutritional state, whereas
the serum concentration of haptoglobin and the white cell count decreased reﬂecting decreased inﬂammatory activity.
Conclusions. This study shows that preoperative TPN for at least 18 days may be recommended to be given to patients
with moderate to severe CD until clinical remission is achieved in order to minimize the risk of early postoperative
complications.
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Introduction
In 1932, Crohn’s disease (CD) was clearly described
as an entity by B. B. Crohn and colleagues, who
reported 14 patients who had been operated by
Dr. A. A. Berg [1]. Accumulating evidence suggests
that CD results from an inappropriate response to
intestinal microbes in a genetically susceptible host
[2]. Since about 70% of all patients with CD ulti-
mately come to surgery [3], and of all patients under-
going ﬁrst resections for CD nearly 50% will
ultimately require a second operation [4], there has
been considerable interest in the outcome of surgical
treatment for this condition.
The results of surgical treatment of CD at the
Mount Sinai Hospital, where B. B. Crohn worked,
were reviewed in 1945, when the overall mortality for
primary resection was over 13%, and in 1985 when
there was no mortality in a series of 130 patients [5].
However, 30% of these 130 patients studied devel-
oped postoperative complications, which were classi-
ﬁed as major in 8% [5].
Emergency surgery is seldom necessary in CD.
Thus, spontaneous free perforation and perforated
abscess were found to occur in only 2.1% in a series of
1415 CD cases [6].
Whereas malnutrition has been associated with
increased postoperative mortality and morbidity rates
since 1936 [7,8], convincing evidence of signiﬁcant
reduction of postoperative complications by preoper-
ative total parenteral nutrition (TPN) is rare and
sometimes controversial [9,10].
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preoperative TPN was compared with a series of
matching CD patients who had not been given pre-
operativeTPN.Ifarelationshipbetweenpreoperative
TPN and absence of postoperative complications
exists, a signiﬁcantly higher rate of postoperative
complications would be expected to be present in
the series of CD patients, who had not received
preoperative TPN.
Patients, materials, and methods
Cases
The cases consisted of a series of 15 consecutive CD
patients given preoperative TPN (nil per os) during
18–90 days (mean, 46 days) followed by intestinal
resection with primary handsewn anastomosis end-
to-end usually performed with a single-layer of inter-
rupted absorbable synthetic suture material (Dexon)
(group 1). In one patient, only the sigmoid colon was
resected, in another one the intestine on both sides of
a jejunocolonic anastomosis was resected, whereas in
the other 13 patients an ileocolonic resection was
performed. All patients were given infection prophy-
laxis with antibiotics postoperatively [11]. The pre-
operative TPN was given on medical grounds while
the patients were hospitalized. The diagnosis of CD
was based on the ﬁndings at histologic examination
[12]. During the period studied, no CD patient in a
seriousconditionwasrefusedpreoperativeTPN.CD
patientswithonlysymptomsofintestinalstenosisand
no sign of malnutrition and no particular sign of
inﬂammation were not included in the study. All
patients gave their informed consent prior to their
inclusioninthestudy,whichwasperformedinaccor-
dance with the ethical standards laid down in the
1975 Declaration of Helsinki.
The clinical data of the patients in group
1 are presented in Tables I and II. Intestinal resec-
tion had previously been performed in six patients.
At the introduction of TPN, three patients were
given prednisolone, 10–40 mg/24 h, but none
received or had received treatment by means of
biologicals.
Controls
Age, sex, disease pattern, type of operation, and the
number of previous operations for CD are factors that
may all relate to the rate of postoperative complica-
tions. To control for the potential effects of these
factors, a sevenfold multiple of controls (the highest
obtainable multiple) were matched to the 15 cases on
the basis of the above-mentioned factors. The con-
trols were consecutively selected from all the 692 CD
patients operated without preoperative TPN at the
14 acute hospitals in Stockholm County during a
20-year period ending a few years before the begin-
ning of the present series of 15 CD cases studied [13].
Matchingwasaccomplishedinthreesteps.First,the
controls,whohadundergonethesametypeofintestinal
resection and anastomosis and had the same disease
pattern and had undergone the same number of pre-
vious operations (l, 2, or 3–9) for CD as one of the
15 cases, were matched to each such case. Second, the
sevenfold matching was adjusted on the basis of sex,
andthird,onthebasisofage(withinthesamedecade).
For one case operated with segmental resection of
the colon, controls had to be selected from both sexes
and from four decades to obtain seven corresponding
controls. For three other but between themselves
similar cases, only 20 corresponding controls were
found within the limitations set; an extra control free
from postoperative complication was therefore
included to obtain a sevenfold matching. For yet
another case, only six corresponding controls were
found; again an extra complication-free control was
included for the same reason. Thus, 105 controls
constituting group 2 were found matching to the
15 CD cases.
Before the preoperative TPN given to group 1 and
before intestinal resection in group 2, there was no
difference in steroid treatment and treatment by
means of biologicals between the patients in groups
1 and 2.
Infusion solutions and procedures
In the TPN given group 1, the infusion solutions
included amino acids (Vamin with glucose or fructose,
Table I. Clinical data for the patients in group 1 at introduction of total parenteral nutrition.
Number Sex Age (yr) Height (cm)
Body weight
(kg) BMI
a (units) CDAI
b (units)
M/F Mean SD Mean SD Mean SD Mean SD Mean SD
Group 1 15 4/11 35 12 172 9 54 9 18.6 1.8 270 107
aBMI = body mass index = weight/(height)
2;
bCDAI = Crohn’s disease activity index [40].
Postop. complications in Crohn’s disease 171Pharmacia, Stockholm, Sweden), carbohydrates, fat
emulsion (Intralipid 10% or 20%, Pharmacia) [14],
electrolytes, trace elements (Addamel, Pharmacia),
and vitamins (Soluvit and Vitalipid Adult, Pharmacia)
[15]. The TPN regimens provided 9.8–13.1 MJ
(2350 to 3100 kcal) of energy per 24 h (8.8 to 11.5
non-protein MJ/24 h) in 2.5–3.6 liter/24 h including
53–106 g of fat (only two patients were given 106 g
of fat per 24 h; the others received 53–56 g/24 h),
65–438 g of glucose, 113–234 g of fructose, 6–11 g of
glycerol (in the fat emulsion, Intralipid 10% and 20%),
3–4.5 g of sorbitol (in the trace element solution,
Addamel), 9.4–14.1 g of nitrogen, 160–195 mmol
sodium, 70–110 mmol potassium, 7.5–11.3 mmol cal-
cium, 4.1–9.5 mmol magnesium, 13.5–19.5 mmol
phosphate, one ampoule of Soluvit (water-soluble
vitamins), one ampoule (10 ml) of Vitalipid Adult
(fat-soluble vitamins), and 10–15 ml of Addamel.
The intravenous infusions were given for about 14 h
daily (08.00–22.00 h) by gravity drip through a central
venous catheter (CVC). A heparin lock was placed for
the remainder of the 24-h period. The duration of the
preoperative TPN in group 1 was 46 ± 22 days
(mean ± SD).
In the early cases of the series, all infusion com-
ponents were mixed at the pharmacy. In the last two
cases, the fat emulsion, including the water- and fat-
soluble vitamins, was given from 08.00 to 14.00 h and
the mixture of the other infusion components, deliv-
ered from the pharmacy in a 3-liter plastic bag (Tra-
venol, Thetford, Norfolk, England), was given from
08.00 to 22.00 h; the fat emulsion and the carbohy-
drate–amino acid solution were mixed as they passed
through the CVC. To reduce the risk of CVC-
related thrombosis, ﬁve of the last patients were given
heparin intravenously, 5000 IU/6 h [16].
One of the cases was given 0.5 liter of packed
erythrocytes on days 11–12 of the preoperative
TPN. The blood component therapy was given for
anemia, which had been present at the introduction of
TPN. None of the other cases was given whole blood
or blood components during the preoperative TPN.
Deﬁnition of early postoperative complications
Early postoperative complications are deﬁned as com-
plications within 30 days postoperatively [17]. Wound
infection was deﬁned as spontaneous discharge of pus
from the wound. Perforation with free peritonitis was
documented at laparotomy. A wound dehiscence
required operative re-closure and intestinal obstruc-
tion required laparotomy for decompression. Enter-
ocutaneous ﬁstula was documented radiologically and
by the discharge of intestinal contents through the
abdominal wall. Entero-enteric ﬁstula was revealed at
laparotomy, occasionally by barium enema preoper-
atively. A perianal ﬁstula was disclosed by a ﬁstulous
opening adjacent to the anus. Intraabdominal abscess
and anastomotic leakage were documented at opera-
tion. Intraabdominal bleeding required laparotomy
for hemostasis. Pneumonia was documented by an
abnormal chest roentgenogram.
Analytical methods
After an overnight fast (12–14 h), venous blood sam-
ples were drawn on one of the 3 days preceding TPN
and at intervals during the period of TPN before the
daily infusion was started. In blood (B-) reticulocytes,
white cell count (WBC) and the concentration
of hemoglobin (Hb) and in serum (S-) or plasma
(P-) the concentrations of albumin, orosomucoid,
a1-antitrypsin, haptoglobin, asparagine aminotrans-
ferase (ASAT), alanine aminotransferase (ALAT),
alkaline phosphatase (ALP), total bilirubin, choles-
terol, triglycerides (TG), triiodothyronine (T3), thy-
roxine (T4), thyrotropic hormone (TSH), and the
immunoglobulins G, A and M (IgG, IgA, and IgM,
respectively) were determined by the conventional
methods used at Huddinge Hospital. Free fatty acids
(FFA) in serum were determined by a gas chro-
matographic method [18]. Total phospholipids
(PL) in serum were determined according to Svan-
borg and Svennerholm [19] and individual PL
according to Vikrot [20].
Univariate comparisons of proportions were made
by the c
2 test with Yates’s correction. The statistical
Table II. Disease pattern and previous operations for Crohn’s
disease (CD) in the patients of group 1 when total parenteral
nutrition (TPN) was introduced.
Disease pattern
Group 1
n = 15
Ileitis 8
a
Ileocolitis 5
b
Colitis 2
c
aOne patient had undergone exploratory laparotomy 1.5 months
earlier. Another patient had undergone ileocecal resection 4 years
earlier. A third patient had undergone appendectomy and ileo-
transversostomy 7 years and 1 month earlier, respectively, and a
fourth patient had undergone appendectomy and ileocecal resec-
tion 7 and 6.5 years earlier, respectively;
bOne patient had under-
gone appendectomy and segmental resection of the ileum 11 and
2 years previously, respectively. Another patient had undergone
colonectomy one month earlier and a third patient had undergone
appendectomy, ileocecal resection, exploratory laparotomy, and
two ileocolonic resections 35, 4, 3, 2, and 2 years earlier, respec-
tively;
cOne patient had undergone appendectomy, ileotransver-
sostomy, and ileocolonic resection 22, 20, and 19 years previously,
respectively.
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pairedandunpairedt-tests.Foralltests,apvalueofless
than 0.05 was considered signiﬁcant. The results are
reported as the mean ± standard deviation (SD).
Results
During the preoperative TPN, all the cases in group
1 displayed clinical remission of CD – as judged from
their general well-being, relief of abdominal pain, and
abatement of fever and diarrhea. Although enterocu-
taneous and perianal ﬁstulas healed and abdominal
mass disappeared during the TPN, there were more
or less stenotic intestinal CD changes remaining,
which were removed at the following operation.
When clinically sufﬁcient remission had been
achieved, but X-ray examination showed remaining
intestinal stenosis, bowel resection was considered
indicated. At operation, CDAI was estimated to be
well below 150 in every TPN patient, and CDAI
<150 is considered to be in remission by this measure.
There was no signiﬁcant postoperative complica-
tion in the TPN group, whereas there were 29 patients
with postoperative complications in group 2 (Table III).
This is a higher rate of complications (p < 0.05) than
in group 1. During the preoperative TPN, however,
there were some complications but no central line-
associated blood stream infection. Thus, because of
CVC-associated thrombosis usually presented as
ceased infusion, one patient successively was given
ﬁve CVC:s during 45 days of preoperative TPN (she
had been given TPN for 2 months as the sole therapy
7–9 months earlier and then probably developed
subclavian and superior caval vein thromboses, angio-
graphically veriﬁed after the fourth CVC; the last
CVC was introduced via vena saphena magna),
another patient needed three consecutive CVC:s dur-
ing 76 days of preoperative TPN, a third needed two
CVC:s during 54 days of preoperative TPN, and a
fourth patient also needed two CVC:s during 47 days
of preoperative TPN, whereas the remaining
11 patients had uneventful courses of preoperative
TPN. When the fourth patient with CVC-
associated thrombosis after 31 days of preoperative
TPN was to be given the second CVC, an attempt to
insert a subclavian intravenous catheter resulted in a
pneumothorax cured by 5 days of Bülau drainage. At
operation, all TPN patients were in good condition.
All patients in group 1 were discharged from Hud-
dinge Hospital within 30 days postoperatively (17 ±
7 days); the last eight cases were discharged after only
12 ± 4 days. Because of relatively low Hb values on the
day of operation, without excessive blood loss eight
patients in group 1 received blood transfusion, on the
average 0.65 ± 0.51 liter of whole blood whereas
during the remaining period at Huddinge Hospital,
no more blood was given. Hb usually decreased
during the ﬁrst week of TPN probably due to rehy-
dration by the TPN given. During the following
period of preoperative TPN, Hb slowly increased,
but the increase was not statistically signiﬁcant
(Table IV). In three patients, the prednisolone ther-
apy was discontinued during or shortly after TPN. In
two patients, where prednisolone was introduced
during TPN, the corticosteroid medication was dis-
continued 10 weeks after TPN.
The progress on the preoperative TPN given group
1issummarizedinTableIV.Duringtherelevantperiod
ofTPN,thebodyweight(BW)andthebodymassindex
(BMI)increased,asdidalsotheserumconcentrationsof
albumin, cholesterol, T3, IgA, and IgM, whereas the
WBC, S-haptoglobin, and S-TG showed a decrease
(Table IV). There was no metabolic complication
such as hyperglycemia or need for insulin.
The liver function tests, S-ASAT, S-ALAT, and
S-ALP, displayed no signiﬁcant change, although
S-ALP attained a level slightly above the normal range
at the end of the preoperative period of TPN. The
serum concentrations of both total and individual
phospholipids showed increases during the TPN,
and after 1.5 months of TPN, total S-phospholipids,
S-lecithin, and S-sphingomyelin had attained levels
above the corresponding reference levels.
Discussion
The use of TPN as adjunct therapy for CD is cur-
rently used to improve nutritional status for surgery,
but TPN only has not been found to be an alternative
to resection [21]. Rombeau et al. [22] have found
fewer surgical complications and lower mortality in a
TPN-treated group compared with a control group,
and Lashner et al. [10] reported that preoperative
Table III. Distribution of postoperative complications in 29 of the
105 patients in group 2.
Complication Number of patients
Death 1
Wound complication 14
Intestinal obstruction 6
a
Fistula 4
Anastomotic leakage 2
Other
b 2
Total 29
aOne patient had moreover anastomotic leakage;
bOne had blood
transfusion hepatitis and another patient suffered a very compli-
cated postoperative course including enterocutaneous ﬁstula,
abscess in the rectouterine pouch and cachexia.
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bowel resection at the expense of longer hospital
stay in bowel resection in CD.
Central venous catheterization is a well-established
procedure, but there is a risk of complications on
insertion of a CVC by percutaneous subclavian cath-
eterization [23]. Although there were no severe lasting
consequences related to the preoperative TPN, since
all patients studied were in good condition when the
intestinal resection was performed, it may be worth
trying to shorten the preoperative TPN period from
the mean of 46 days in this study to decrease the need
of more than one CVC. Thelong average preoperative
TPN period depended on that in the ﬁrst patients,
the TPN given was initially intended to be the sole
therapy, but as intestinal resection could not be
avoided, the goal for the preoperative TPN was short-
ened to 3 weeks with prolongation if necessary until
acceptable remission had been achieved.
The control population was consecutively selected
from all CD patients operated in Stockholm County
during a preceding 20-year period, which probably
will mean that some of them were not seriously ill at
resection, whereas the 15 patients studied in a referral
center were selected because they had a severe period
of CD and intestinal resection could not be avoided.
Although not calculated, it is therefore likely that the
average CDAI of the control population was lower
than the mean of the 15 TPN patients studied, as the
controls included all patients and not only those with
nutritional deﬁcits and signs of inﬂammatory activity.
The groups were not contemporaneous, but since
there was no difference between them in preoperative
treatment before the TPN given to group 1, they
should be able to be compared.
In a study of 84730 patients who had undergone
inpatient general and vascular surgery from 2005
through 2007 in ﬁve categories of hospitals in the
USA, a rate of overall postoperative complications
between 24.6% and 26.9% was found, whereas the
rate of major complications varied between 16.2%
and 18.2% [24]. After colonectomy, the rate of all
postoperative complications varied between 24.7%
and 28.1% [24], which is in accordance with the
Table IV. Progress on preoperative total parenteral nutrition (TPN); selected blood (B-), serum (S-), and plasma (P-) concentrations
(group 1).
Before TPN At the end of TPN
Component Mean SD n Mean SD n Reference range
Body weight (kg) 54.3 9.4 14 56.7** 8.3 14
Body mass index (units) 18.6 1.8 14 19.4** 1.6 14
B-hemoglobin (g/l) 107 12 13 112 10 14 115–165
Reticulocytes (%) 0.6 0.4 7 0.9 0.6 10 0.2–1.0
White cell count (10
9/l) 10.1 3.6 11 5.7* 1.8 12 3.0–9.0
S-albumin (g/l) 34 6 13 39** 4 14 38–55
P-orosomucoid (g/l) 1.5 0.5 6 1.1 0.4 7 0.4–0.8
P-antitrypsin (g/l) 3.3 2.0 9 1.9 0.3 11 0.8–1.7
S-haptoglobin (g/l) 3.4 1.2 10 2.3** 0.9 13 0.4–2.5
S-ASAT (mkat/l) 0.35 0.33 13 0.47 0.43 14 0–0.70
S-ALAT (mkat/l) 0.37 0.74 13 0.62 0.99 14 0–0.70
S-ALP (mkat/l) 3.62 2.29 12 4.70 3.57 13 0–4.20
S-bilirubin, total (mmol/l) 7 3 11 9 4 13 0–26
S-cholesterol (mmol/l) 3.4 1.3 11 5.3** 1.2 12 2.6–6.4
S-triglycerides (mmol/l) 1.2 0.4 10 1.0* 0.4 12 0–2.2
S-free fatty acids (mmol/l) 0.70 0.26 5 0.95 0.36 7 0.15–0.92
S-triiodothyronine (nmol/l) 1.5 0.5 5 2.0* 0.5 8 1.2–2.3
S-thyroxine (nmol/l) 125 28 4 106 18 8 58–167
S-thyrotropic hormone (units/l) 2 1 4 3 2 5 0–6
S-immunoglobulin G (g/l) 11 3 10 13 4 13 7–17
S-immunoglobulin A (g/l) 3.0 1.7 10 3.1* 1.8 12 0.6–5.0
S-immunoglobulin M (g/l) 1.7 0.8 10 2.6** 1.0 12 0.7–3.7
S-phospholipids, total (mmol/l) 2.42
a 0.52 7 3.63*
b 0.20 5 2.41–3.05
c
S-cephalin (mmol/l) 0.07
a 0.02 7 0.12
b 0.03 5 0.07–0.10
c
S-lecithin (mmol/l) 1.66
a 0.34 7 2.60*
b 0.21 5 1.46–2.00
c
S-lysolecithin (mmol/l) 0.17
a 0.07 7 0.27
b 0.04 5 0.17–0.32
c
S-sphingomyelin (mmol/l) 0.53
a 0.12 7 0.64
b 0.05 5 0.43–0.57
c
aIn two cases measured on days 20 and 28, respectively, before TPN. Their states of malnutrition did not change clinically until TPN was
instituted;
bMeasured on days 46–57 of TPN;
cWagener et al. [41].
*Signiﬁcant difference from the value before TPN (p < 0.05); **Signiﬁcant difference from the value before TPN (p < 0.01).
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2 (27.6%) in the present study.
During the period of preoperative TPN, the nutri-
tional state improved as reﬂected in increases in BW,
BMI, S-albumin [25,26], S-T3, and S-cholesterol,
and the inﬂammatory activity in the intestines dimin-
ished as reﬂected in the decreases in WBC and
S-haptoglobin. The changes in B-hemoglobin,
P-orosomucoid, P-antitrypsin, and S-IgA pointed in
the same advantageous directions, although they did
not achieve statistical signiﬁcance. Several mechan-
isms that are not mutually exclusive have been pro-
posed to explain the apparent beneﬁcial action of
TPN in active CD [27].
A weakness of studies of TPN therapy for CD has
been the failure to include controls to account for the
natural history of the disease and the large placebo
effect associated with the treatment of the disease
[28]. Although prospective randomized controlled
trials have become the accepted scientiﬁc standard
for evaluating therapeutic efﬁcacy, clinical nutrition
research is not well suited for this methodology [29].
In this study, it is not possible to determine which of
the variables studied is most important to improve
during the TPN to minimize the risk of postoperative
complications, although the increase in S-albumin
may be crucial [30], since the S-albumin concentra-
tion may reﬂect both the nutritional state and the
degree of inﬂammatory activity in CD [26]. If there
would be no increase in S-albumin after 3 weeks of
TPN, the TPN may be prolonged if it is possible, until
an increase is obtained, since absence of increase in
S-albumin may be associated with increased risk of
postoperative complications [25]. Moreover, the risk
of developing postoperative complications has been
found to be inversely related to the concentration of
S-albumin [30]. Also the absence of respiratory com-
plications found may be explained by the improved
nutritional state during the preoperative TPN [31].
The minimum effective dose of preoperative TPN
could not be determined accurately in the study pre-
sented. Lashner et al. [10] surmised that preoperative
TPN formorethan10daysinCDhadlittle conﬁrmed
beneﬁcialeffectintheirsample,buttheirTPNpatients
started on S-albumin levels around 35–37 g/l and may
thushavehadsomewhatlessnutritionaldeﬁcitsandless
inﬂammationthanthepatientsingroup1whoseinitial
level was around 34 g/l.
The increase in BW during the preoperative
TPN given may also have contributed to a decreased
risk of postoperative complications, since recent
preoperative weight loss is a basic indicator of surgical
risk [32].
The increase in S-T3 within the normal range, while
S-T4 showed no signiﬁcant change in this study, may
reﬂect a normalization of the resting metabolic rate
(RMR) from a state of relative starvation or under-
feeding with lowered RMR [33]. Thyroid hormones
carry a major responsibility for regulating the RMR.
T3 production is decreased in starvation with little
change in T4 production rates [34]. The concentra-
tions of total, free and production rates of the ther-
mogenic hormone, T3, are increased by overfeeding
and decreased by underfeeding in concert with the
changes in RMR that are found in these conditions
[33]. Since there is a strong correlation between the
changes in total T3 concentrations and the relative
amount kcal/24 h/kg fat free mass [33], the increase in
S-T3 found probably reﬂects an improvement in the
RMR in the lean patients studied.
Despite no adverse clinical effect was observed
such as liver function disturbance, the increases
above reference values in the serum phospholipids
during the TPN studied are remarkable, but may be
explained by the fact that by the 500 ml Intralipid
10% given daily, 12 g of egg-yolk phospholipids were
provided per 24 h, an amount that may be unnec-
essary high. However, the manufacturing pharma-
ceutical company has, after this study, diminished
the content of phospholipids to 6 g in 500 ml
Intralipid 10%.
Since there is an association between blood trans-
fusion and increased rates of postoperative bacterial
infections [35,36], and only one patient was given
blood transfusion during the preoperative TPN stud-
ied and seven patients received no blood at opera-
tion, this restraint with blood transfusion may also
have contributed to the absence of postoperative
complications.
It is desirable to be able to diminish or discontinue
prednisolone administration during TPN, because
the protein catabolic rate will increase if the prednis-
olone dose is increased, and there is an increased risk
of postoperative as well as infectious complications
following the preoperative use of corticosteroids in
patients with CD [37], although Bruewer et al. [38]
found no increased postoperative complication rate.
Thus, when the signs of clinical remission were unsat-
isfactory during steroid-free TPN, there showed to be
no drawback to include prednisolone to induce a
satisfactory preoperative remission in the two patients
who were clinically judged to need this drug [39];
both had an uneventful postoperative recovery and
were off the prednisolone medication 10 weeks later.
Consequently, this study shows that preoperative
TPN for at least 18 days may be recommended to be
given to patients with moderate to severe CD until
clinical remission is achieved in order to minimize the
risk of early postoperative complications after intes-
tinal resection and primary anastomosis.
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